Filing Details

Accession Number:
0001181431-15-008054
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-09 16:46:04
Reporting Period:
2015-06-05
Filing Date:
2015-06-09
Accepted Time:
2015-06-09 16:46:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302106 D Ryan Drant 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-05 1,869,159 $10.70 7,488,893 No 4 P Indirect See Note 1
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 1
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Acquisiton 2015-06-05 560,748 $0.13 560,748 $13.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
560,748 2015-06-05 2020-06-05 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 533 Direct
Common Stock 59 Indirect See Note 2
Footnotes
  1. The Reporting Person is a manager of NEA 12 GP, LLC, ("NEA 12 GP") which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 12 in which the Reporting Person has no pecuniary interest.
  2. The securities are directly held by the Ryan Drant 2006 Family Trust. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by the Ryan Drant 2006 Family Trust in which the Reporting Person has no pecuniary interest.
  3. Acquired from the issuer pursuant to a Securities Purchase Agreement dated June 2, 2015, with a closing date of June 5, 2015.